Drawing for SOLUTIONS MADE REAL

USPTO serial 86130555

SOLUTIONS MADE REAL

Reviewed by CopyMark Law Group

Reg. 4654201Status 710
Filing date
Status date
Registration date
Dec 9, 2014
Examiner
NEVILLE, BRIAN
Law office
TMO LAW OFFICE 114

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with SOLUTIONS MADE REAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

William M. Bryner

William M. Bryner Kilpatrick Townsend & Stockton LLP1001 West Fourth StreetWinston-Salem, NC 27101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Business management, business strategy, business consultancy and advisory services for the pharmaceutical, medical device, food and healthcare industries; market research, namely, collecting market trends data from providers and patients, data on health economic issues, and competitive intelligence data on the marketplace for pharmaceutical products and medical devices; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting and analysis; administering customer service programs, namely, operating patient assistance programs for pharmaceutical products and medical devices, and providing access to advocacy groups and counseling for patients to promote patient satisfaction; information and advisory services relating to the foregoingSECTION 8 - CANCELLED—
036Providing a database featuring information and statistics about patient reimbursement and insurance coverage for pharmaceuticals and medical devicesSECTION 8 - CANCELLED—
042Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; research and development of antibodies for in vitro and in vivo use; custom design and development of chemical reagents and biochemical assays; consulting services for others in the field of design, planning, and project management of scientific research, drug development, and clinical trials; medical and scientific research, namely, designing, organizing, conducting, and managing clinical trials for others; clinical research services, namely, collection, calibration, analysis and reporting of data in connection with clinical trials; scientific laboratory services; laboratory research services relating to pharmaceuticals, medical devices, biotechnology, biochemicals, antibodies, molecules for drug development, biomarker analysis, pharmacology, toxicology, drug metabolism, pharmacokinetics, biology, immunochemistry, health vaccines, pathology, and isotope chemistry; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of biomarkers, genomics, proteomics, and genotyping; computer software design; development, updating and maintenance of software and databases; data mining; providing temporary use of on-line non-downloadable software for tracking, monitoring, analyzing, and reporting information and statistics in the fields of pharmaceutical and medical device development studies, clinical trials, patient reimbursement and insurance coverage, and biological research; food safety testing and consultation related thereto; scientific consulting and research services relating to food, food packaging, and nutritional chemistry; information and advisory services relating to the foregoingSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 20, 2025CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9—
Dec 9, 2023REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Sep 7, 2022ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 7, 2021NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Apr 7, 2021C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Apr 7, 2021APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 22, 2020E815TEAS SECTION 8 & 15 RECEIVED—
Dec 9, 2019REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Sep 20, 2018ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 20, 2018REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 9, 2014R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 1, 2014SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Oct 31, 2014CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Oct 1, 2014SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Oct 1, 2014AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Sep 17, 2014IUAFUSE AMENDMENT FILED—
Sep 17, 2014EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 17, 2014NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Apr 22, 2014NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 22, 2014PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 2, 2014NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 13, 2014CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 12, 2014DOCKASSIGNED TO EXAMINER—
Dec 11, 2013NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 30, 2013NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance